FERMT2 and esophageal squamous cell carcinoma: Our previous studies have reported that miR-200b suppresses the invasiveness of ESCC in vitro via repressing the cytoskeletal and the adhesive machinery, and Kindlin-2 was identified as a direct target and functional mediator of miR-200b [11].